Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 45,000 shares at $35.41 ($1.6M) on 2019-09-11, disclosed to the SEC on 2019-09-13.
Open-market sale of $1.6M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.81 | 16,349 | $569K | 36.2% |
| 2 | $34.81 | 16,349 | $569K | 36.2% |
| 3 | $35.41 | 6,151 | $218K | 13.8% |
| 4 | $35.41 | 6,151 | $218K | 13.8% |
| Total | $34.97 avg | 45,000 | $1.6M | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |